CCNB1 and hepatocellular carcinoma: This proposed axis of SIRT4-dependent inhibition of survivin and retention of cytoplasmic cyclin B1 in the suppression of tumor cell cycle progression and induction of apoptosis could shed light on the development of therapeutic targets against HCC tumorigenesis.